Loading…
CIK 0001844645 • 6 13F filings • May 14, 2025 – Aug 13, 2026
Import this data to Google Sheets with:
=jivedata("pivotal-bioventure-partners-investment-advisor-llc","13f")Uses this filer's slug. Install the Jive Data add-on first; the second argument is "13f".
Past 5 quarters
| % of Portfolio | |||||
|---|---|---|---|---|---|
| ARCUTIS BIOTHERAPEUTICS INC | COM | $39.7M | 15.3%Prev: 23.1% | 1,366,624 SH | Decreased-753,884 SH |
| BIOAGE LABS INC | COM | $8.6M | 3.3%Prev: 2.2% | 653,374 SH | Increased |
| BOLT BIOTHERAPEUTICS INC | COM NEW | $517K | 0.2%Prev: 0.3% | 94,573 SH | Increased |
| EVOMMUNE INC | COM SHS | $33.0M | 12.8% | 1,926,943 SH | New |
| IMMUNOME INC | COM | $15.7M | 6.1%Prev: 3.4% | 732,512 SH | Increased+230,000 SH |
| MAPLIGHT THERAPEUTICS INC | COM | $10.7M | 4.2% | 611,447 SH | New |
| OCULIS HOLDING AG | ORDINARY SHARES | $45.7M | 17.7%Prev: 23.4% | 2,288,658 SH | Increased-12,116 SH |
| RALLYBIO CORP | COM | $1.6M | 0.6%Prev: 0.7% | 2,404,644 SH | Increased |
| RECURSION PHARMACEUTICALS IN | CL A | $2.4M | 0.9%Prev: 1.7% | 595,518 SH | Decreased |
| TREVI THERAPEUTICS INC | COM | $15.7M | 6.1%Prev: 6.6% | 1,256,782 SH | Increased |
| VAXCYTE INC | COM | $63.3M | 24.5%Prev: 28.6% | 1,372,425 SH | Increased |
| ZENAS BIOPHARMA INC | COM | $21.5M | 8.3%Prev: 10.0% | 591,991 SH | Increased-187,054 SH |
| Q2 2026 |
| 13F-HR |
| 0001012975-26-000759 |
| $307.8M |
| View |
| Aug 13, 2025 | Q2 2025 | 13F-HR | 0001012975-25-000438 | $161.3M | View |
| May 14, 2026 | Q1 2026 | 13F-HR | 0001012975-26-000421 | $279.8M | View |
| May 14, 2025 | Q1 2025 | 13F-HR | 0001012975-25-000233 | $123.6M | View |